N-acetyl Selank Amidate
Overview
N-acetyl Selank Amidate is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, modified with acetylation and amidation to increase half-life and central nervous system activity. It is reported to exert anxiolytic and nootropic effects through modulation of enkephalin metabolism and influencing monoamine neurotransmitter systems without sedation or dependency. The peptide has been explored for anxiety, cognitive enhancement, and stress adaptation.
Key Research Findings
Preclinical studies in rodents have shown anxiolytic effects comparable to benzodiazepines but without adverse effects on motor coordination or memory, with publications in behavioral pharmacology journals. Small clinical studies conducted in Russia have reported subjective improvements in anxiety and cognitive performance, but these lack the rigor and replication of international randomized trials. The compound is not approved by major Western regulatory agencies.
Intranasal
Investigational
Interested in N-acetyl Selank Amidate?
Find a verified provider experienced with N-acetyl Selank Amidate protocols in your area. All providers are credentialed and use compliant sourcing.
Find a N-acetyl Selank Amidate ProviderRelated Peptides
Semax
FDA ApprovedA synthetic heptapeptide analog of the ACTH(4-7) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) with nootropic and neuroprotective properties. Semax modulates BDNF and NGF expression, enhances monoaminergic neurotransmission, and provides neuroprotection through anti-oxidant and anti-inflammatory mechanisms. It crosses the blood-brain barrier via intranasal administration.
Selank
InvestigationalA synthetic analog of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with an added Pro-Gly-Pro sequence for stability. Selank exhibits anxiolytic activity comparable to benzodiazepines without sedation, dependence, or withdrawal effects. It modulates the expression of BDNF, serotonin, dopamine, and norepinephrine, and influences IL-6 and GABA receptor expression.
Cerebrolysin
InvestigationalA porcine brain-derived peptide preparation consisting of low-molecular-weight neuropeptides and free amino acids that mimic the action of endogenous neurotrophic factors. Cerebrolysin exhibits neurotrophic activity similar to BDNF, GDNF, and CNTF, promoting neuronal survival, synaptic plasticity, and neurogenesis. It modulates GSK-3beta, CDK5, and calcineurin-NFAT signaling cascades involved in neurodegeneration.
P21 (Peptide)
Research PhaseA small synthetic peptide derived from the active region of ciliary neurotrophic factor (CNTF) designed to promote neurogenesis and synaptic plasticity. P21 is a tetrapeptide that crosses the blood-brain barrier and enhances dentate gyrus neurogenesis by increasing BDNF expression. Unlike full-length CNTF, P21 does not activate the JAK-STAT pathway or produce the anorectic and immunogenic effects of the parent protein.